Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Osiris Therapeutics, Inc.    OSIR   US68827R1086

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
10/27/2014 10/28/2014 10/29/2014 10/30/2014 10/31/2014 Date
13.46(c) 13.95(c) 13.7(c) 14.02(c) 13.46 Last
64 488 112 075 92 890 65 359 184 044 Volume
-0.59% +3.64% -1.79% +2.34% -3.99% Change
More quotes
Company
Osiris Therapeutics, Inc. is a stem cell company, which focuses on developing and marketing products to treat medical conditions in the inflammatory, cardiovascular, orthopedic and wound healing markets.The company operates its business through two segments: Therapeutics and Biosurgery segment.The... 
Surperformance© rating of Osiris Therapeutics, Inc.
Trading Rating : - Investor Rating :
More about the company
Chart OSIRIS THERAPEUTICS, INC.
Duration : Period :
Osiris Therapeutics, Inc. Technical Analysis Chart | OSIR | US68827R1086 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 54,5 M
EBIT 2014 -3,74 M
Net income 2014 2,35 M
Debt 2014 -
Yield 2014 -
Sales 2015 82,5 M
EBIT 2015 6,70 M
Net income 2015 10,3 M
Debt 2015 -
Yield 2015 -
PER 2014 254,91
PER 2015 47,53
Capi. / Sales 2014 8,83x
Capi. / Sales 2015 5,83x
Capitalization 481 M
More Financials
Latest news on OSIRIS THERAPEUTICS, INC.
4d ago OSIRIS THERAPEUTICS : and Arthrex Sign Exclusive Commercial Partnership for Cart..
6d ago OSIRIS THERAPEUTICS : Sets Date for Third Quarter Results Release
10/22 OSIRIS THERAPEUTICS : and Arthrex Ink Exclusive Commercial Partnership for Carti..
10/17 OSIRIS THERAPEUTICS : and Arthrex announce an exclusive partnership for the comm..
10/16 OSIRIS THERAPEUTICS : to present three studies on benefits of cryopreserved plac..
10/16 OSIRIS THERAPEUTICS : Schedules Third Quarter Results Release
10/13 OSIRIS THERAPEUTICS : Announces Third Quarter 2014 Financial Results Conference ..
10/04 OSIRIS THERAPEUTICS : to Present at the 2014 Stem Cell Meeting on the Mesa
09/25 OSIRIS THERAPEUTICS : to Present at the 2014 Stem Cell Meeting on the Mesa
09/24 OSIRIS THERAPEUTICS : Grafix® Featured in Plenary Session Oral Presentation at t..
09/18 OSIRIS THERAPEUTICS : Presents at Joint Annual Meeting of the Eastern and New En..
09/17 OSIRIS THERAPEUTICS : Grafix® Randomized Controlled Clinical Trial Recognized as..
More news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF